Lenvatol 4mg Capsule

Current price is: ₹1,150.00. Original price was: ₹1,747.97.

You saved ₹597.97 (34%)

Brand Name: Lenvatol

Category: Anti Cancer

Manufacturer: Cipla Ltd

Composition: Lenvatinib

Minimum Order Quantity: 2

10 Capsule(s) In A Strip

Lenvatol 4mg Capsule is used for Thyroid cancer. Lenvatol 4mg Capsule contains an oral receptor tyrosine kinase inhibitor in capsules. Your doctor will decide what dose is right for you according to your treatment needs.

Lenvatol 4mg Capsule may affect or be affected by other medicines you are taking. Tell your doctor if you have any heart, liver or kidney problems or are taking any antiviral treatments. Both males and females should use effective contraception during therapy. Pregnancy is not recommended during pregnancy or nursing.

Product Description

Lenvatol 4mg Capsule contains Lenvatinib, an oral receptor tyrosine kinase inhibitor used in the treatment of thyroid cancer and certain other advanced cancers. Your doctor will determine the appropriate dose based on your medical condition and treatment requirements.


Uses of Lenvatol 4mg Capsule

  • Thyroid Cancer
  • Renal Cell Carcinoma
  • Hepatocellular Carcinoma

How does the Lenvatol 4mg Capsule work?

Lenvatinib is a multi-kinase inhibitor that targets several receptor tyrosine kinases involved in tumour angiogenesis, growth, and proliferation. It blocks Platelet-Derived Growth Factor Receptor (PDGFR), Fibroblast Growth Factor Receptors (FGFR1-4), Vascular Endothelial Growth Factor Receptors (VEGFR1, VEGFR2, and VEGFR3), KIT, and RET. By blocking these pathways, it helps slow tumour growth and reduces the tumour’s blood supply.


How to Use & Dosage

Lenvatol 4mg Capsule may be taken with or without food. Swallow the capsules whole without crushing, breaking, or chewing them.

The usual recommended dose for differentiated thyroid cancer is 24 mg once daily. The dosage may vary depending on the condition being treated. For renal cell carcinoma and hepatocellular carcinoma, the recommended starting dose is often 18 mg once daily or as directed by your doctor.

Take this medicine by mouth with a full glass of water. Follow your prescription carefully and take it regularly. Do not stop taking the medicine without consulting your healthcare provider. If prescribed for children, follow your doctor’s advice. In case of overdose, seek emergency medical attention immediately.


Possible Side Effects

  • Hypertension
  • Fatigue
  • Diarrhea
  • Decreased appetite
  • Nausea
  • Vomiting
  • Heart failure
  • Blood clots (thromboembolism)

Safety Advice

🩺 Kidney

Lenvatol 4mg Capsule should be used with caution in patients with kidney disease. Dose adjustment may be required. Please consult your healthcare provider.

⚠️ Liver

Use Lenvatol 4mg Capsule with caution if you have liver disease. Dose adjustment may be necessary. Please consult your healthcare provider.

🤰 Pregnancy

Lenvatol 4mg Capsule may cause harm to the unborn baby and is generally not recommended during pregnancy. Please discuss the risks with your healthcare provider.

🤱 Breastfeeding

Lenvatol 4mg Capsule is not recommended while breastfeeding because the medicine may pass into breast milk and could harm a nursing infant. Please consult your healthcare provider.

🍺 Alcohol

It is not known whether it is safe to consume alcohol while taking Lenvatol 4mg Capsule. Please consult your healthcare provider.

🚗 Driving

Lenvatol 4mg Capsule may affect your ability to concentrate or react. If you experience symptoms such as dizziness or fatigue, avoid driving or operating machinery.


Storage Instructions

Store at room temperature (20°C to 25°C). Keep the capsules in a dry place away from moisture and direct sunlight. Store in the original packaging and keep out of the reach of children.


References

  • FDA (Eisai). LENVIMA (lenvatinib) Full Prescribing Information. 2021.
  • Schlumberger M, Tahara M, Wirth LJ, et al. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer. N Engl J Med. 2015;372(7):621-630.
  • Motzer RJ, Hutson TE, Glen H, et al. Lenvatinib, Everolimus, and the Combination in Patients with Metastatic Renal Cell Carcinoma. Lancet Oncol. 2015;16(15):1473-1482.
  • Kudo M, Finn RS, Qin S, et al. Lenvatinib versus Sorafenib in First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma. Lancet. 2018;391(10126):1163-1173.
  • Goodman & Gilman’s. The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill.

Disclaimer

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.


Frequently Asked Questions (FAQs)

1. What is Lenvatol 4mg Capsule? 💊

Lenvatol 4mg Capsule contains Lenvatinib, an oral targeted therapy (kinase inhibitor). It may be prescribed for the treatment of certain advanced cancers.

2. How does Lenvatinib work? ⚙️

Lenvatinib inhibits multiple receptor tyrosine kinases involved in tumour blood vessel formation and cancer cell growth. This may help slow tumour progression.

3. What conditions is it prescribed for? 🩺

Lenvatol 4mg Capsule may be prescribed for locally recurrent or metastatic thyroid cancer, advanced renal cell carcinoma, and unresectable hepatocellular carcinoma (liver cancer).

4. How should I take Lenvatol 4mg Capsule? 💊

It is usually taken by mouth once daily and may be taken with or without food. Always follow your doctor’s instructions.

5. What is the usual dose? 📋

The dose depends on the type of cancer being treated. You may need to take multiple 4mg or 10mg capsules together as prescribed by your oncologist.

6. What are the possible side effects? ⚠️

Possible side effects include high blood pressure, fatigue, diarrhea, decreased appetite, weight loss, and hoarseness of voice.

7. Are there any serious cardiovascular risks? ❤️

Yes. Lenvatol 4mg Capsule may increase the risk of severe hypertension, heart dysfunction, and arterial thromboembolic events such as heart attack or stroke.

8. Do I need regular blood pressure monitoring? 🩸

Yes. Blood pressure should be monitored before starting treatment and regularly during therapy because this medicine may significantly increase blood pressure.

9. Can it affect the liver or kidneys? 🩺

Yes. Lenvatol 4mg Capsule may affect liver and kidney function. Your doctor may recommend regular blood tests to monitor these organs.

10. Is it safe during pregnancy? 🤰

No. Lenvatinib may cause fetal harm and is generally not recommended during pregnancy. Effective contraception is usually recommended during treatment.

11. What should I do if I vomit after taking a dose? 🤢

If you vomit after taking a capsule, do not take another dose. Take your next scheduled dose at the usual time on the following day unless your doctor advises otherwise.

12. Is Lenvatol 4mg Capsule a prescription medicine? 📄

Yes. Lenvatol 4mg Capsule is a prescription-only cancer medicine and should only be used under the supervision of a qualified healthcare professional.


Medical Disclaimer

Lenvatol 4mg Capsule is a prescription-only medicine and must be used only under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, change the dosage, or stop taking the medicine without consulting your doctor. The information provided here is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your healthcare provider before starting, stopping, or changing any medication.